baber/WOPTO huggingface dataset:
Patent AU-2935092-A (AU)
Title: Process, medium and device for electrodialytically regenerating the electrolyte of a galvanic bath or the like
IPC: B01D61/52
Filed: 1992-11-13
Abstract: For the purpose of electrodialytic purification of the electrolyte of an electroplating bath, a pickling bath or the like, the bath fluid (process electrolyte), in order to be continuously regenerated, is passed in a closed circulation through a first chamber (21) of an electrodialysis cell (20). The first chamber (21) has a wall designed as a semipermeable membrane (33) and is immersed within a bath formed by a second larger chamber (22). The second chamber (22) holds an auxiliary electrolyte which is separated from the process electrolyte by the membrane (33). The one chamber (21) or (22) holds the anode (31), and the correspondingly other chamber holds the cathode (32) of an electric DC current source (30). This apparatus enables the electrodialytic regeneration process for the process electrolyte to be operated continuously. To this end, the auxiliary electrolyte is passed in a close circulation through the second chamber (22) which is used as the auxiliary electrolyte bath and holds the first chamber (21). The auxiliary electrolyte used is preferably a carboxylic acid. The auxiliary electrolyte preferably contains a supporting electrolyte. <IMAGE>
Patent AU-3063101-A (AU)
Title: A novel isoform of human camp-dependent protein kinase, calpha-s, localizes to sperm midpiece and the use thereof
Inventor: REINTON NILS
IPC: A61K48/00
Filed: 2000-12-21
Abstract: The cloning of a novel human Calpha isoform, identified as the human Calpha-s protein on the basis of its similarity to a recently characterized Calpha isoform which was identified by purification and peptide sequencing of Calpha from ovine sperm. The human Calpha-s protein was present in testis and ejaculated sperm and Calpha-s localized to the midpiece of human sperm. A cDNA sequence encodes a Calpha-s protein and includes the specific nucleotide sequence shown in SEQ ID NO:1, wherein the protein is a new splice variant of Calpha catalytic subunit of cAMP dependent protein kinase.
Patent AU-3156301-A (AU)
Title: Device for separating strips and uses of such a device
Inventor: GRAVERT PETER
IPC: B65H1/00
Filed: 2000-12-09
Abstract: A device for isolating strips conveyed next to another in lengthwise direction is constituted by at least one separating unit which is extended parallel to a lengthwise axis. Each strip is assigned to one guide and it is inserted and guided by the guides in a plane running essentially parallel to the lengthwise axis of the separating unit and different for neighboring guides. When the strips are inserted into the guides, the guides are adjustable from a starting position, in which the strips have a slight lateral interval, into a separable position, in which a larger interval exists between the strips.
Patent AU-3247484-A (AU)
Title: Structural display frame
Inventor: BANNISTER BRIAN CHARLES
IPC: E04B2/74
Filed: 1984-08-28
Abstract: A display device comprises a plurality of frames each comprising two uprights and two cross members, bounding a rectangular space in which a rectangular flexible sheet is supported in tension by tensioning devices displaced in the corners of the frame. Laterally adjoining frames are pivotally connected together by links and engage one another via masking gear segments mounted on the tensioning devices. Vertically superimposed frames are connected together by connectors each connecting, end to end, the lower end of one upright of an upper frame and the axially aligned upper end of a lower frame. Each connector comprises an upper peg, a lower peg and an axially slidable and rotatable sleeve captive on the upper peg and capable of being screwed down over the lower peg.
Patent AU-3268695-A (AU)
Title: An arrangement for automatically transporting a vehicle frm a drive-in module to a parking place in a vehicle parkig building
Inventor: ENGMAN BENGT
IPC: E04H6/24
Filed: 1995-08-14
Abstract: PCT No. PCT/SE95/00923 Sec. 371 Date Feb. 18, 1997 Sec. 102(e) Date Feb. 18, 1997 PCT Filed Aug. 14, 1995 PCT Pub. No. WO96/05390 PCT Pub. Date Feb. 22, 1996A vehicle transporting arrangement for transporting a vehicle in a parking building automatically from a drive-in module to a parking space (27), wherein the arrangement includes a first carriage (1), a so-called transfer carriage, which can be moved on and between different parking floors or storeys of the parking building and which includes a second carriage (2) and a third carriage (3), each of which includes lifting devices (4, 5, 6, 7) for lifting and supporting a pair of vehicle wheels, the second and third carriages being positioned sequentially in a direction perpendicular to the direction of movement of the first carriage on a parking floor and being movable in relation to the first carriage at right angles to its direction of movement on a parking floor. According to the invention, at least one of the second and the third carriages (2, 3) includes drive wheels (10) and drive elements for moving the carriage in relation to the first carriage (1).
Patent AU-3448300-A (AU)
Title: Insulating glazing unit provided with a blind
Inventor: ROSSINI MAURO
IPC: E06B9/262
Filed: 2000-03-16
Abstract: An insulating glazing unit internally provided with a blind which is adapted to be moved from a fully gathered condition to an unfolded condition, and vice versa. The blind, in the gathered configuration, is arranged in the lower part and interacts with an arrangement for pulling a flap in order to unfold it from the bottom upward until the insulating glazing unit is fully blacked out.
Patent AU-3520300-A (AU)
Title: Systems and methods for resolving gps pseudo-range ambiguity
Inventor: WICKSTROM DANIEL
IPC: G01S5/00
Filed: 2000-03-08
Abstract: Methods and systems are provided for determining a position of a mobile terminal that includes a satellite radiotelephone and a global positioning system (GPS) receiver based on knowledge of the position of the communication satellite spot-beam in which the mobile terminal is located. Using knowledge of the location of the communication satellite spot-beam, the present invention can resolve the one-millisecond ambiguity, that typically arises from the code repeat length where relative code phase may be determined but absolute code phase (i.e. one millisecond increments) could be off by one or more code periods. The spot-beam identifier is obtained from the satellite communication system and used to determine the geographic location of the spot-beam. Trial positions, i.e., candidate mobile terminal positions, are then selected to cover the spot-beam area, with spacing between trial positions provided to account for the one-millisecond ambiguity. Pseudo-range measurements are generated for each trial position and used to generate position fixes. The best position fix, for example a fix selection based on a self-consistency check, is then selected as the mobile terminal's position. In an additional aspect of the present invention, the number of trial positions is reduced by selecting an arc of positions within the spot-beam as trial positions based on timing delay information from the satellite communication system.
Patent AU-3614895-A (AU)
Title: Preparation of protein microspheres, films and coatings
Inventor: COOMBES ALLAN GERALD ARTHUR
IPC: A61K9/38
Filed: 1995-10-10
Abstract: A process is described for preparing microspheres, films and coatings from protein or modified protein in which the protein product is stabilized by carrying out the preparation in the presence of an aqueous solution of at least one alpha-hydroxy acid. Preferred alpha-hydroxy acids are glycolic acid, lactic acid, alpha-hydroxybutyric acid or a mixture of two or more thereof. The microspheres, films and coatings so produced have improved stability in aqueous solution.
Patent AU-3625393-A (AU)
Title: Method of carrying out cryosurgical interventions and device for this method
Inventor: STRAUS JAROSLAV
IPC: A61B18/02
Filed: 1993-03-22
Abstract: PCT No. PCT/CZ93/00004 Sec. 371 Date Sep. 22, 1994 Sec. 102(e) Date Sep. 22, 1994 PCT Filed Mar. 22, 1993 PCT Pub. No. WO93/18714 PCT Pub. Date Sep. 30, 1993A method of carrying out cryosurgical interventions includes cooling biological tissue at a rate of at least 180 K/min to a temperature of -190 DEG  C. to -160 DEG  C., subsequently rewarming the biological tissue at a rate of 100 to 240 K/min to a temperature of -70 DEG  C. to -20 DEG  C. with a subsequent rewarming at a rate of 10 to 25 K/min to a temperature of -5 DEG  C. to +5 DEG  C., and further rewarming the biological tissue up to body temperature. The total time of the controlled rewarming of the biological tissue is shorter than 5 minutes. An apparatus for carrying out the method of cryosurgical interventions includes a container of cooled medium an operating instrument, and a control unit for controlling the cooling and subsequent rewarming of biological tissue. The control unit includes a microprocessor coupled to electronic switches and a measuring unit.
Patent AU-3637793-A (AU)
Title: Mycobacterium vaccae for treatment of long term autoimmune conditions
Inventor: STANFORD JOHN LAWSON
IPC: A61K35/74
Filed: 1993-02-19
Abstract: Antigenic and/or immunoregulatory material derived from Mycobacterium vaccae is useful in the treatment of the auto immunologically mediated consequences of Chaga's disease or the prophylaxis or treatment of vascular diseases or complications which may be immunologically mediated such as those associated with tuberculosis or diabetes.
Patent AU-3727193-A (AU)
Title: Topical aromatic releasing compositions
Inventor: HUGHES TIMOTHY JOHN
IPC: A61K8/81
Filed: 1993-02-22
Abstract: The present invention relates to topical aromatic releasing compositions substantially free from petrolatum and containing one or more volatile aromatic compounds selected from the group consisting of menthol, camphor and eucalyptus oil and mixtures thereof. In further embodiments, these compositions contain one or more topical actives, and are also useful for providing relief from symptoms associated with respiratory disorders.
Patent AU-3807293-A (AU)
Title: Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans
Inventor: GRISAR J MARTIN
IPC: C07D311/58
Filed: 1993-03-12
Abstract: This invention relates to novel hydrazide acyl hydrazinium derivatives of certain 3,4-dihydro-2H-1-benzopyrans of formula (1), the stereoisomers and mixtures thereof, their inner salts, and the pharmaceutically acceptable salts thereof wherein R is H or C1-6 alkyl, R1 is C1-6 alkyl, R2 is H or -C(O)R, R3 and R4 are independently C1-6 alkyl; R5 is C1-6 alkyl, or (a) with R8 being H or halogeno, n is zero, 1, 2, or 3 and X is a halide, -S(O)3R6, or nothing when the inner salt is formed, R6 is H, C1-6 alkyl, phenyl or 4-methylphenyl, to the intermediates, processes and techniques for their preparation, to their ability to manifest the property of being free radical scavengers, and to their end-use application in the treatment of disease conditions capable of being ameliorated by free radical scavengers.
Patent AU-3814799-A (AU)
Title: Chiral phosphorated ligands useful in catalysts
Inventor: PICCOLO ORESTE
IPC: C07F9/6584
Filed: 1999-04-09
Abstract: Described herein are new atropo-isomeric chiral phosphorated ligands having C1 symmetry, the procedure for their preparation, the organometallic complexes containing said ligands in optically active form, and the use of said complexes as catalysts in stereoselective syntheses.
Patent AU-3848799-A (AU)
Title: Controlled release preparations having multi-layer structure
Inventor: SANO AKIHIKO
IPC: A61K9/24
Filed: 1999-05-19
Abstract: Preparations whereby two or more drugs can be released separately at appropriate speeds depending on the disease or the release behaviors of one or more drugs can be precisely controlled, which consist of an outer layer wherein a water-soluble drug is dispersed in a carrier made of a biologically non-degradable and hydrophobic polymer material, and one or more inner layers wherein a water-soluble drug, differing in type or concentration from the one contained in the outer layer, is dispersed in a carrier made of a biologically non-degradable and hydrophobic polymer material, and in which the outer and inner layers are concentrically located in the diametral direction of stick type preparations and both or one of the ends in the axial direction are opened so as to directly come into contact with the environment.
Patent AU-3850993-A (AU)
Title: Ink, ink-jet recording process making use of the ink, and equipment therefor
Inventor: SHIMOMURA MASAKO
IPC: B41J2/175
Filed: 1993-05-11
Abstract: Provided is an ink containing a recording agent and a liquid medium capable of dissolving or dispersing the recording agent, wherein said ink comprises a compound represented by the formula    R1R2NCONHCH2CH2OH   wherein R1 and R2 each represent hydrogen or CnH2nOH, where n is 2 or 3, provided that R1 and R2 are not hydrogen at the same time, and has a pH of not less than 7 to less than 10. <IMAGE>
Patent AU-4049300-A (AU)
Title: Non-linear distortion generator
Inventor: ZHOU SHUTONG
IPC: H03F1/32
Filed: 2000-03-29
Abstract: An in-line distortion generator for coupling in-line with a non-linear device (NLD) produces an output signal of useful amplitude, but with low composite second order, composite triple beat and cross modulation distortions. The distortion generator comprises an instant controlled non-linear attenuator which utilizes the non-linear current flowing through a pair of diodes, in parallel with a resistor and an inductor, to provide the proper amount of signal attenuation over the entire frequency bandwidth. The distortion generator circuitry is always matched to the NLD, thereby ensuring a frequency response that is predictable and predefined. The distortion generator may also include a temperature compensation circuit to ensure consistent operation throughout a wide temperature range.
Patent AU-4094097-A (AU)
Title: Dry-air-surface heat exchanger
Inventor: KINNEY OHLER L
IPC: F28C1/00
Filed: 1997-08-28
Abstract: A dry-air-surface heat exchanger is provided for use in a liquid cooling tower, and includes a plurality of preformed, shape-retaining heat transfer members of relatively thin synthetic resin sheet material. Each member presents a pair of upright, side-by-side panels that are preferably folded together about a vertical axis to present inward-facing wet-transfer surfaces adapted to transfer heat between the fluid and the member, and an outward-facing dry-transfer surface adapted to transfer heat between the member and air. The folded member is configured to present a series of tortuous liquid flow paths between the panels extending between the upper and lower edges, and the side edges are secured together in substantially fluid tight sealing engagement. A plurality of the folded members are provided in a pack, and a diffuser is positioned adjacent to the upper edges of the folded members for receiving hot liquid and directing the hot liquid between the panels of each member. The diffuser seats against the upper edges to substantially uniformly distribute the fluid to be cooled into the fluid passages while keeping the air passages therebetween free of fluid. The ratio of the total vertical, cross-sectional area of the liquid passages through the heat transfer members with respect to the total vertical, cross-sectional area of the air passages between the heat transfer members is from about 0.67 to about 1.5.
Patent AU-4097097-A (AU)
Title: A device for dispensing a flowable substance
Inventor: HAMMEN KLAUS
IPC: A61C5/62
Filed: 1997-10-14
Abstract: A device suited for dispensing a dental substance comprises a cartridge 20 for receiving the substance, with a curved dispensing nozzle 22 disposed at the front end and a flange 21 of octagonal cross-section provided at the rear end of the cartridge. The flange 21 serves to engage a slide-in socket 16 of an applicator 10 which includes a piston rod 12 for advancing a dispensing piston 23 disposed in the cartridge 20. In the retracted position of the piston rod 12, the cartridge 20 may be laterally inserted into the slide-in socket 16 of the applicator 10. The socket has two parallel walls spaced by a distance which is between the largest and the smallest diameter of the octagonal flange 21. The material of the flange 21 and/or the material forming the slide-in socket 16 is resilient so that the cartridge 20 may be stepwise rotated about the axis of the piston rod 12 with respect to the applicator 10 without requiring the piston rod 12 to be withdrawn and the cartridge 20 to be removed from the slide-in socket and re-inserted in a new orientation.
Patent AU-4138296-A (AU)
Title: Continuously variable hydrostatic transmission including a pulse width modulation ratio controller
Inventor: LARKIN ROBERT FRANCIS
IPC: F15B11/08
Filed: 1995-10-31
Abstract: A controller for changing the ratio of a continuously variable hydrostatic transmission, as determined by the angular position of a swashplate, including an actuator having a cylinder slidingly receiving a piston to define a pair of chambers. A pair of solenoid valves, each configured to connect a respective chamber selectively to sump pump pressure or atmospheric pressure, are energized with a stream of pulses to create differential fluid pressures in the chambers, thereby producing movement of the piston; the piston movement being linked to the swashplate to produce a corresponding adjustment of the swashplate angular position. The rate of change of the swashplate angular position is controlled by pulse width modulating the pulse stream.
Patent AU-4325300-A (AU)
Title: Labyrinth package for sutures
Inventor: CERWIN ROBERT J
IPC: A61B17/06
Filed: 2000-03-03
Abstract: A labyrinth package for sutures. The package has a base member with a top and a bottom. A labyrinth wall member extends from the top of the base member upwardly to form a labyrinth channel. The channel has an open end and a closed end. There is a vacuum opening in the bottom of the channel adjacent to the closed end. A lid is placed on top of the package. The package is loaded with sutures by using a combination of a vacuum source applied to the vacuum opening and a venturi air stream feed.
Patent AU-4368799-A (AU)
Title: Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases
Inventor: EISENBRAND GERHARD
IPC: C07D209/34
Filed: 1999-05-26
Abstract: The present invention relates to the use of indigoid bisindole derivatives for the manufacture of a medicament for inhibiting cyclin dependent kinases, particularly CDK 1, CDK 2, CDK 4 and CDK 5, more particularly ATP:Proteinphosphotransferase p34<cdc2> (CDK1).
Patent AU-4397489-A (AU)
Title: Building system
Inventor: ARTHUR REYNOLDS DONALD
IPC: E04B2/96
Filed: 1989-11-02
Abstract: An opening window for use with curtain wall systems comprising an outer frame (42) adapted to fit to the framework members of the curtain wall system and an inner frame (48) bearing the glazed portion of the window, the inner frame (48) and the outer frame (42) being hingedly attached to one another and the glazed portion extending so as to be substantially coextensive with the outer frame (42). The appearance of this window does not detract from the sight lines of the building and yet the flexibility of the system is not impaired.
Patent AU-4441289-A (AU)
Title: New insulin derivatives, the use thereof, and a pharmaceutical composition containing them
Inventor: DORSCHUG MICHAEL
IPC: C12N15/09
Filed: 1989-11-06
Abstract: Insulin derivatives of the formula II with an isoelectric point between 5 and 8.5, with improved stability in weakly acid aqueous medium and with specific action profile and the physiologically tolerated salts of these insulin derivatives for the treatment of diabetes mellitus; formula II is: <IMAGE> in which R<1> is H or H-Phe, R<2> is a genetically encodable L-amino acid which contains no amide group, R<3><0> is the residue of a neutral, genetically encodable L-amino acid, R<3><1> is a physiological acceptable organic group which is basic in nature and has up to 50 C atoms, in whose structure 0 to 3  alpha -amino acids are involved and whose terminal carboxyl group which is present where appropriate can be free, in the form of an ester, in the form of an amide, in the form of a lactone or reduced to CH2OH, and X is a genetically encodable L-amino acid.
Patent AU-4450097-A (AU)
Title: Vehicle testing device
Inventor: MULLER ROLAND
IPC: G01M17/04
Filed: 1997-08-29
Abstract: The invention relates to a vehicle testing device for carrying out various tests on a vehicle, with the tires of the vehicle being respectively placed on two driveable rotatable rollers. Known vehicle testing devices have a need for substantial space and incur high production costs. Object of the invention is to enable a less expensive and more compact inspection of the vehicle. According to the invention, this is attained by placing a shock absorber testing device in the area of both rollers. The additional axial displacement of the rollers and provision of a third roller disposed in parallel relationship thereto and also shiftable in axial direction enables a testing of brakes, tracking, steering play, joint play as well as shock absorbers in a smallest space.
Patent AU-4492685-A (AU)
Title: Unwetting composition based on fluorochlorohydrocarbon, surface active agent and carboxylic acid
Inventor: JEAN-PIERRE REMOND
IPC: C03C23/00
Filed: 1985-06-24
Abstract: The composition based on fluorochlorohydrocarbon contains a surface active agent resulting from the reaction of a quaternary ammonium chlorhydrate with an alkyl phosphoric acid in the presence of a fluor-containing amine and a carboxylic acid. The separation rate of the aqueous and organic phase is improved.
Patent AU-4548997-A (AU)
Title: Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
Inventor: KRATZ FELIX
IPC: A61K35/00
Filed: 1997-09-09
Abstract: The following are claimed; (1) conjugate addition derivatives (A) of transferrin and albumin are new. The conjugates comprise a thiolated transferrin or albumin and a cytostatic (doxorubicin, daunorubicin, epirubicin, idarubicin, chlorambucil, melphalan, 5-fluorouracil, 5'-deoxy-5-fluorouridine, or cisplatin analogue of formula (I)) derivatised with a maleimide compound of formula of formula (IV). The coupling bond between the maleimide and the cytostatic is an amide, ester, imine, hydrazone, acyl, benzoylhydrazone, oxycarbonyl, acetal or ketal. R' = (CH2)nX, p = 0 and R" = H; or R' = H, p = 0 or 1; R" = (CH2)nX; n = 0-6; X = NH2, OH, OCO(CH2)nCOCR'; R' = H, phenyl or 1-6C alkyl; R = 1-6C aliphatic and Y = Y1; or R = benzyl or optionally substituted phenylene and Y = Y2; Y1 = Y2 or CONHNH2; Y2 = OH, COOH, COCl, COO(CH2)nOH, COO(CH2)nNH2, COO(CH2)nNHNH2, SO3H, SO3Cl, SO2NHNH2, OCOCl, CHO or COR'. (2) bismaleimide derivatives of formula (V). Z = CONH(CH2)mNHCO, COO(CH2)mOCO, C=NH(CH2)mNH=C, C=NNH(CH2)mNHN=C, C=NNHCO(CH2)mCONHN=C; and m = 2-12. (3) chemoimmunoconjugates comprising albumin loaded with 5-30 equivalents of a cytostatic compound as in (1) conjugated to a protein, such as transferrin or a monoclonal antibody against a tumour-associated antigen, especially transferrin, via (V) or an aliphatic or aromatic bismaleimide compound.